Funded Projects

Ruthenium-peptide conjugates:
arrows for selectively targeting breast cancer

Arrows2cancer

Arrows2cancer mission is to develop an innovative and precise chemotherapeutic for triple negative breast cancer.

FCT-logo.png
RP logo_edited.png

PTDC/QUI-QIN/0146/2020  

Funding: € 249.9k

Sem Título.png